Breaking Diagnostics Barriers

Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care (POC). Mesa Biotech's Accula™ System consists of a portable, palm-sized dock and disposable, assay-specific test cassettes. This patented system enables healthcare professionals to access actionable, laboratory-quality results at the POC with greater sensitivity and specificity than current infectious disease rapid immunoassay tests.

The Accula Flu A/Flu B and the Accula RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA). Both products are distributed in the US and Canada by Sekisui Diagnostics under the SilarisÔ brand. Mesa Biotech has secured a number of strategic agreements for distribution in Europe and Asia.

 
icon1.png

What We Do

Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care (POC).

icon2.png

Our Goal

Mesa Biotech tests will make Point of Care DNA and RNA testing available to a much larger population segment than alternative legacy solutions providing healthcare providers information to more effectively treat patients



icon3.png

Our Technology

Mesa Biotech's Accula™ System consists of a portable, palm-sized dock and disposable, assay-specific test cassettes. This patented system enables healthcare professionals to access actionable, DNA and RNA laboratory-quality results at the POC with greater sensitivity and specificity than current infectious disease rapid immunoassay tests.


For more information contact Mesa Biotech headquarters at:

Mesa Biotech Inc.
6190 Cornerstone Court East, Suite 220
San Diego, CA 92121
Phone: 858-800-4929
Email: Info@mesabiotech.com